Mounjaro is a once-weekly injection that is FDA approved to be used to decrease blood sugar (blood glucose) in adults who have type 2 diabetes. It should be used together with diet and exercise. Mounjaro has also been shown in clinical trials to be useful for weight loss.
More Information:
● Mounjaro works to reduce blood sugar levels by increasing your insulin production and also lowering the amount of sugar your liver makes.
● It also slows the rate food passes through your body which makes you feel full longer.
● Mounjaro (Tirzepatide) is the first dual GIP/GLP-1 receptor agonist which means it works on the glucose-dependent insulinotropic polypeptide (GIP) receptors and the glucagon-like peptide-1 (GLP-1) receptors.
● Mounjaro can be used as a single therapy or with other diabetes medicines including metformin, sulfonylureasor SGLT2 inhibitors.
● It is not known if this medicine can be used in people who have had pancreatitis.
● Mounjaro is not for use in people with type 1 diabetes.
Benefits:
• Regulates blood sugar levels in people with type 2 diabetes.
• Promotes weight loss.
• Reduces appetite and increases the feeling of being full.
• Improves blood sugar control.
Before using Mounjaro:
• Tell your doctor and pharmacist if you are allergic to Mounjaro, any other medications, or any of the ingredients in this injection. Ask your pharmacist or check the medication Guide for a list of the ingredients.
• Tell your doctor if you have or have ever had pancreas or kidney disease, stomach problems such as difficulty digesting food, or history of diabetic retinopathy.
• Tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking this medicine, call your doctor.